Yinuorui Company has been granted a new authorized invention patent.

Recently, YinoRi Company received an invention patent certificate for the “Analytical Method for Detecting Heparin Sulfate Impurities in Sodium Heparin,” with patent number ZL2019114119108. The patent was filed on December 31, 2019, and was authorized and announced on July 5, 2022.
 
   

   Obtaining this invention patent will optimize the impurity detection method for sodium heparin, further enhancing the company’s product quality.

In recent years, with strong support from Hongri Pharmaceutical, Yinuorui Company has gradually refined its intellectual property system and successfully earned the title of Huanggang Municipal-Level Demonstration Enterprise for Intellectual Property Construction in 2021. Looking ahead, under the technical guidance of Hongri Pharmaceutical, Yinuorui will continue to enhance its technological innovation capabilities and strategic application skills, thereby strengthening its overall competitive edge.